Azimuth Capital Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.43M Buy
18,265
+122
+0.7% +$43.5K 0.24% 129
2025
Q4
$5.94M Sell
18,143
-569
-3% -$180K 0.21% 134
2025
Q3
$5.28M Buy
18,712
+127
+0.7% +$36.8K 0.19% 135
2025
Q2
$5.19M Buy
18,585
+346
+2% +$98K 0.19% 138
2025
Q1
$5.68M Sell
18,239
-460
-2% -$136K 0.23% 130
2024
Q4
$4.87M Sell
18,699
-6,387
-25% -$1.89M 0.19% 143
2024
Q3
$8.08M Buy
25,086
+617
+3% +$202K 0.31% 108
2024
Q2
$7.65M Buy
24,469
+488
+2% +$143K 0.31% 105
2024
Q1
$6.82M Buy
23,981
+1,074
+5% +$314K 0.28% 122
2023
Q4
$6.6M Sell
22,907
-160
-0.7% -$43.6K 0.3% 115
2023
Q3
$6.2M Sell
23,067
-373
-2% -$93.1K 0.31% 117
2023
Q2
$5.2M Buy
23,440
+70
+0.3% +$16.2K 0.25% 131
2023
Q1
$5.65M Buy
23,370
+330
+1% +$81K 0.28% 129
2022
Q4
$6.05M Sell
23,040
-704
-3% -$189K 0.31% 118
2022
Q3
$5.35M Sell
23,744
-945
-4% -$229K 0.29% 123
2022
Q2
$6.01M Buy
+24,689
New +$6.05M 0.3% 122

Other funds holding AMGN

Azimuth Capital Investment Management's AMGN Position: Q1 2026 in Review

Azimuth Capital Investment Management increased its Amgen (AMGN) stake by 0.67% in Q1 2026, buying an estimated $43.5K and bringing the position to 18,265 shares worth $6.43M. The position accounts for 0.24% of the portfolio, ranked #129.

Azimuth Capital Investment Management first reported a position in AMGN in Q2 2022 and has held it in 16 quarters since. The position peaked at $8.08M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Azimuth Capital Investment Management held 18,265 shares of Amgen worth $6.43M as of Q1 2026.
  • Azimuth Capital Investment Management bought 122 Amgen shares in Q1 2026, an estimated $43.5K.
  • Amgen made up 0.24% of Azimuth Capital Investment Management's portfolio in Q1 2026, its #129 holding.
  • Azimuth Capital Investment Management first reported a position in Amgen in Q2 2022 and has held it in 16 quarters since.
  • Azimuth Capital Investment Management's Amgen position peaked at $8.08M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q1 2026, filed 12 May 2026.